Oliver Keown
Fondateur chez Intuitive Ventures/VC/
Profil
Oliver is managing director and head of Intuitive Ventures.
He joined Intuitive Ventures in 2019 and leads the fund’s investment efforts with a focus on identifying future leaders of minimally invasive care, including early stage startups across digital, medical device, therapeutic and diagnostic domains.
In 2021, Oliver was recognized as a Top 50 Emerging Leader in corporate venture capital and in 2022, selected as #39 on the Global Corporate Venturing Power List of the 100 most influential investors in the industry.
Before coming to Intuitive Ventures, Oliver was a healthcare investor with GE Ventures, driving international startup deal flow and supporting numerous portfolio companies operationally and at the board level.
Prior to that, he advised an array of UK, US and global healthcare innovation projects across technology, government, commercial, and academic fields.
He began his career as a doctor and policy advisor in the UK National Health Service.
He remains dedicated to bringing new technologies, diverse partnerships and investment to address healthcare‘s biggest unmet needs.
He is a widely published author in the fields of healthcare and surgical innovation, and is an advisory board member of the Newsom administration‘s California Initiative to Advance Precision Medicine.
Oliver serves as an investor and Board Observer of Intuitive Ventures portfolio companies, Flywheel.io, Endogenex, SurgeTx, Optellum and KelaHealth.
Oliver holds an MD and BSc in pharmacology from the University of Edinburgh, Scotland.
Postes actifs de Oliver Keown
| Sociétés | Poste | Début |
|---|---|---|
Intuitive Ventures/VC/
 Intuitive Ventures/VC/ Investment ManagersFinance Intuitive Ventures/VC/ (Intuitive Ventures) is a venture capital firm founded in 2020 by Oliver Keown. The firm is headquartered in Sunnyvale, California. | Fondateur | 01/01/2019 |
Prellis Biologics, Inc.
 Prellis Biologics, Inc. BiotechnologyHealth Technology Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA. | Consultant / Advisor | 01/01/2019 |
Anciens postes connus de Oliver Keown
| Sociétés | Poste | Fin |
|---|---|---|
GE Ventures LLC
 GE Ventures LLC Investment ManagersFinance GE Ventures LLC (GE Ventures) is a venture capital subsidiary of General Electric Co. founded in 2000 by James Kim. The firm is headquartered in Menlo Park, California. | Analyste en capital-investissement | 31/08/2019 |
| Imperial College London | Consultant / Advisor | 01/09/2016 |
| INTUITIVE SURGICAL, INC. | Directeur/Membre du Conseil | - |
Formation de Oliver Keown
| The University of Edinburgh | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTUITIVE SURGICAL, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
GE Ventures LLC
GE Ventures LLC Investment ManagersFinance GE Ventures LLC (GE Ventures) is a venture capital subsidiary of General Electric Co. founded in 2000 by James Kim. The firm is headquartered in Menlo Park, California. | Finance |
Intuitive Ventures/VC/
Intuitive Ventures/VC/ Investment ManagersFinance Intuitive Ventures/VC/ (Intuitive Ventures) is a venture capital firm founded in 2020 by Oliver Keown. The firm is headquartered in Sunnyvale, California. | Finance |
Prellis Biologics, Inc.
Prellis Biologics, Inc. BiotechnologyHealth Technology Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA. | Health Technology |